Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks

1. LLY forecasts 2024 revenue of $45 billion, 32% growth forecasted. 2. Fourth-quarter revenue predicted at $13.5 billion, 45% year-over-year growth. 3. 2024 guidance falls short of past estimates by $400 million. 4. Strong performance noted in oncology and neuroscience sectors. 5. Increased manufacturing capacity expected to boost supply availability.